Cargando…

Factors influencing neurocognitive function in patients with neuroepithelial tumors

Though cognitive function is proven to be an independent predictor of survival in patients with intrinsic brain tumors, cognitive functions are still rarely considered. Aim of this study was to assess neurocognitive function and to identify risk factors for neurocognitive deficits. 103 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gempt, Jens, Lange, Nicole, Bette, Stefanie, Foreman, Sarah Charlotte, Cammardella, Jasmin Hernandez, Albertshauser, Jennifer, Gradtke, Corinna, Buchmann, Niels, Ryang, Yu-Mi, Schmidt-Graf, Friederike, Meyer, Bernhard, Ringel, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736700/
https://www.ncbi.nlm.nih.gov/pubmed/29259230
http://dx.doi.org/10.1038/s41598-017-17833-w
_version_ 1783287410387320832
author Gempt, Jens
Lange, Nicole
Bette, Stefanie
Foreman, Sarah Charlotte
Cammardella, Jasmin Hernandez
Albertshauser, Jennifer
Gradtke, Corinna
Buchmann, Niels
Ryang, Yu-Mi
Schmidt-Graf, Friederike
Meyer, Bernhard
Ringel, Florian
author_facet Gempt, Jens
Lange, Nicole
Bette, Stefanie
Foreman, Sarah Charlotte
Cammardella, Jasmin Hernandez
Albertshauser, Jennifer
Gradtke, Corinna
Buchmann, Niels
Ryang, Yu-Mi
Schmidt-Graf, Friederike
Meyer, Bernhard
Ringel, Florian
author_sort Gempt, Jens
collection PubMed
description Though cognitive function is proven to be an independent predictor of survival in patients with intrinsic brain tumors, cognitive functions are still rarely considered. Aim of this study was to assess neurocognitive function and to identify risk factors for neurocognitive deficits. 103 patients with primary neuroepithelial tumors who received tumor resections or biopsies were included in this prospective study. The following data was acquired: mini-mental state examination, preoperative tumor volume, WHO grade, tumor entity and location, and the Karnofsky performance status scale. Furthermore, patients participated in extensive neuropsychological testing of attentional, memory and executive functions. General factors like age, clinical status, WHO grade, tumor volume and tumor location correlated with patients’ neurocognitive functions. Affection of the parietal lobe resulted in significant impairment of attention and memory functions. Frontal lobe involvement significantly affected patients’ abilities in planning complex actions and novel problem solving. Patients with temporal lesions were more likely to have impaired memory and executive functions. Comparing results among neuroepithelial tumor patients enables the identification of risk factors for cognitive impairment. General parameters such as age, KPS score, tumor size, and WHO grade are apart from the respective tumor location of high importance for neurocognitive function.
format Online
Article
Text
id pubmed-5736700
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57367002017-12-21 Factors influencing neurocognitive function in patients with neuroepithelial tumors Gempt, Jens Lange, Nicole Bette, Stefanie Foreman, Sarah Charlotte Cammardella, Jasmin Hernandez Albertshauser, Jennifer Gradtke, Corinna Buchmann, Niels Ryang, Yu-Mi Schmidt-Graf, Friederike Meyer, Bernhard Ringel, Florian Sci Rep Article Though cognitive function is proven to be an independent predictor of survival in patients with intrinsic brain tumors, cognitive functions are still rarely considered. Aim of this study was to assess neurocognitive function and to identify risk factors for neurocognitive deficits. 103 patients with primary neuroepithelial tumors who received tumor resections or biopsies were included in this prospective study. The following data was acquired: mini-mental state examination, preoperative tumor volume, WHO grade, tumor entity and location, and the Karnofsky performance status scale. Furthermore, patients participated in extensive neuropsychological testing of attentional, memory and executive functions. General factors like age, clinical status, WHO grade, tumor volume and tumor location correlated with patients’ neurocognitive functions. Affection of the parietal lobe resulted in significant impairment of attention and memory functions. Frontal lobe involvement significantly affected patients’ abilities in planning complex actions and novel problem solving. Patients with temporal lesions were more likely to have impaired memory and executive functions. Comparing results among neuroepithelial tumor patients enables the identification of risk factors for cognitive impairment. General parameters such as age, KPS score, tumor size, and WHO grade are apart from the respective tumor location of high importance for neurocognitive function. Nature Publishing Group UK 2017-12-19 /pmc/articles/PMC5736700/ /pubmed/29259230 http://dx.doi.org/10.1038/s41598-017-17833-w Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Gempt, Jens
Lange, Nicole
Bette, Stefanie
Foreman, Sarah Charlotte
Cammardella, Jasmin Hernandez
Albertshauser, Jennifer
Gradtke, Corinna
Buchmann, Niels
Ryang, Yu-Mi
Schmidt-Graf, Friederike
Meyer, Bernhard
Ringel, Florian
Factors influencing neurocognitive function in patients with neuroepithelial tumors
title Factors influencing neurocognitive function in patients with neuroepithelial tumors
title_full Factors influencing neurocognitive function in patients with neuroepithelial tumors
title_fullStr Factors influencing neurocognitive function in patients with neuroepithelial tumors
title_full_unstemmed Factors influencing neurocognitive function in patients with neuroepithelial tumors
title_short Factors influencing neurocognitive function in patients with neuroepithelial tumors
title_sort factors influencing neurocognitive function in patients with neuroepithelial tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736700/
https://www.ncbi.nlm.nih.gov/pubmed/29259230
http://dx.doi.org/10.1038/s41598-017-17833-w
work_keys_str_mv AT gemptjens factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT langenicole factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT bettestefanie factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT foremansarahcharlotte factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT cammardellajasminhernandez factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT albertshauserjennifer factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT gradtkecorinna factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT buchmannniels factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT ryangyumi factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT schmidtgraffriederike factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT meyerbernhard factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors
AT ringelflorian factorsinfluencingneurocognitivefunctioninpatientswithneuroepithelialtumors